Sectors
ABEO
Abeona Therapeutics Inc.
5.85
2 x 4.22
2 x 7.42
bid
ask
-
0.07
1.18%
2 @ 07:30 PM
5.85 +0.00 (0.00%)
| Ytd | 11.01% | |
| 1y | -14.35% |
5.78
day range
5.92
4.00
52 week range
7.65
| Open | 5.91 | Prev Close | 5.92 | Low | 5.78 | High | 5.92 | Mkt Cap | 334.53M |
| Vol | 993.56K | Avg Vol | 1.38M | EPS | -1.20 | P/E | N/A | Forward P/E | -3.84 |
| Beta | 1.50 | Short Ratio | 10.79 | Inst. Own | 77.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 6.40 | 200-d Avg | 5.46 | 1yr Est | 16.75 |
| Income Statement | |||
| Total Revenue | 11.38M | ||
| Revenues (USD) | 11.38M | ||
| Cost of Revenue | 4.18M | ||
| Gross Profit | 7.20M | ||
| Operating Expenses | 20.86M | ||
| Research and Development Expense | 5.02M | ||
| Selling, General and Administrative Expense | 15.84M | ||
| Operating Income | -13.65M | ||
| Interest Expense | 696.00K | ||
| Net Income | -20.19M | ||
| Net Income Common Stock | -20.19M | ||
| Net Income Common Stock (USD) | -20.19M | ||
| Consolidated Income | -20.19M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -19.49M | ||
| Earning Before Interest & Taxes (USD) | -19.49M | ||
| Weighted Average Shares | 57.05M | ||
| Weighted Average Shares Diluted | 57.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.23M | ||
| Cash and Equivalents (USD) | 56.23M | ||
| Investments | 90.60M | ||
| Investments Current | 90.60M | ||
| Trade and Non-Trade Receivables | 9.89M | ||
| Current Assets | 164.58M | ||
| Property, Plant & Equipment Net | 14.10M | ||
| Total Assets | 179.51M | ||
| Debt Current | 14.61M | ||
| Total Debt | 19.87M | ||
| Current Liabilities | 24.81M | ||
| Debt Non-Current | 5.26M | ||
| Total Liabilities | 51.45M | ||
| Accumulated Retained Earnings (Deficit) | -779.34M | ||
| Accumulated Other Comprehensive Income | -79.00K | ||
| Shareholders Equity | 128.06M | ||
| Shareholders Equity (USD) | 128.06M | ||
| Assets Non-Current | 14.93M | ||
| Total Debt (USD) | 19.87M | ||
| Deferred Revenue | 677.00K | ||
| Inventory | 5.92M | ||
| Liabilities Non-Current | 26.64M | ||
| Trade and Non-Trade Payables | 2.99M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 833.00K | ||
| Net Cash Flow from Financing | -3.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.14M | ||
| Capital Expenditure | -479.00K | ||
| Issuance (Purchase) of Equity Shares | -1000 | ||
| Issuance (Repayment) of Debt Securities | -3.33M | ||
| Net Cash Flow from Investing | 15.69M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 16.17M | ||
| Net Cash Flow from Operations | -17.50M | ||
| Share Based Compensation | 3.37M | ||